As many as 80% of women will have uterine fibroids in their lifetime. Too many of them will undergo a hysterectomy, experts say.

Uterine fibroids are one of the most common reproductive health conditions—yet they remain shrouded in silence, stigma, and ...

(MENAFN- GlobeNewsWire - Nasdaq) The market opportunities in the global uterine fibroid treatment device sector include rising demand for minimally invasive treatments, increasing prevalence and ...

Huntington Hospital unveils a $3M interventional radiology suite that is designed to offer advanced, minimally invasive ...

About Profound Medical Corp. Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. Profound is ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for ...

These figures are preliminary and unaudited, and actual revenues may differ. The Company plans to announce its full third quarter 2025 financial results after market close on Thursday, November 13, ...

An update from Profound Medical ( ($TSE:PRN) ) is now available. Profound Medical Corp. announced record preliminary unaudited revenues for the ...

Nashville, Tenn.-based AmSurg acquires, develops and operates ASCs with physician groups and has been a key player in the ASC industry for decades. Nancy Daoust, chief ambulatory officer at State ...

An update from Profound Medical ( ($TSE:PRN) ) is now available. Profound Medical Corp. announced its participation in the Stifel 2025 Healthcare ...

In London, Sandra’s consultant specialised in endometriosis and she underwent a six and a half hour operation known as ...

Uterine fibroids are benign tumors that grow in your uterus and can cause painful periods, abnormal bowel movements, and ...